Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What Is This Report About? 9
3 Diabetes Care Devices In Taiwan 10
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, Taiwan, Overall Revenue ($m), 2002-2016 11
3.3 Diabetes Care Devices Market, Taiwan, Revenue Mix ($m), 2009 12
3.4 Diabetes Care Devices Market, Taiwan, Category Contribution (%), 2009 13
3.5 Diabetes Care Devices, Taiwan, Category Volume (Units), 2002-2016 17
3.6 Diabetes Care Devices, Taiwan, Company Share (2008-2009) 20
4 Glucose Monitoring In Taiwan 22
4.1 Glucose Monitoring, Market Segmentation 22
4.2 Glucose Monitoring Market, Taiwan, Revenue Mix ($m), 2009 23
4.3 Glucose Monitoring Market, Taiwan, Category Contribution (%), 2009 24
4.3.1 Glucose Monitoring Overall Revenue (2002-2016) 25
4.3.2 Blood Glucose Meters Revenue (2002-2016) 27
4.4 Glucose Monitoring Overall Volume (2002-2016) 29
4.4.1 Blood Glucose Meters Volume (2002-2016) 31
4.5 Glucose Monitoring Average Price (2002-2016) 33
4.6 Glucose Monitoring Distribution Share (2008-2009) 34
4.7 Glucose Monitoring, Taiwan, Company Share (2008-2009) 35
5 Insulin Delivery In Taiwan 37
5.1 Insulin Delivery, Market Segmentation 37
5.2 Insulin Delivery Market, Taiwan, Revenue Mix ($m), 2009 38
5.3 Insulin Delivery Market, Taiwan, Category Contribution (%), 2009 39
5.4 Insulin Delivery Overall Revenue (2002-2016) 40
5.4.1 Insulin Pens Revenue (2002-2016) 43
5.5 Insulin Delivery Overall Volume (2002-2016) 45
5.5.1 Insulin Pens Volume (2002-2016) 47
5.6 Insulin Delivery Average Price (2002-2016) 49
5.7 Insulin Delivery Distribution Share (2008-2009) 50
5.8 Insulin Delivery, Taiwan, Company Share (2008-2009) 51
6 Overview of Key Companies in Taiwan Diabetes Care Devices Market 53
6.1 F. Hoffmann-La Roche Ltd. 53
6.1.1 Company Overview 53
6.1.2 Share in the Taiwan Diabetes Care Devices Market 53
6.2 LifeScan, Inc. 54
6.2.1 Company Overview 54
6.2.2 Share in the Taiwan Diabetes Care Devices Market 54
6.3 Novo Nordisk A/S 55
6.3.1 Company Overview 55
6.3.2 Share in the Taiwan Diabetes Care Devices Market 55
6.4 Bayer HealthCare AG 56
6.4.1 Company Overview 56
6.4.2 Share in the Taiwan Diabetes Care Devices Market 56
6.5 Sanofi-Aventis 57
6.5.1 Company Overview 57
6.5.2 Share in the Taiwan Diabetes Care Devices Market 57
6.6 ARKRAY, Inc. 58
6.6.1 Company Overview 58
6.6.2 Share in the Taiwan Diabetes Care Devices Market 58
6.7 Terumo Corporation 59
6.7.1 Company Overview 59
6.8 TaiDoc Technology Corporation 60
6.8.1 Company Overview 60
6.9 Smiths Medical 60
6.9.1 Company Overview 60
6.10 Medtronic, Inc. 61
6.10.1 Company Overview 61
6.11 IN4 Technology Corporation 61
6.11.1 Company Overview 61
6.12 Eli Lilly and Company 61
6.12.1 Company Overview 61
6.13 BIONIME Corporation 62
6.13.1 Company Overview 62
6.14 Becton, Dickinson and Company 62
6.14.1 Company Overview 62
6.15 Apex Biotechnology Corp. 63
6.15.1 Company Overview 63
6.16 Animas Corporation 63
6.16.1 Company Overview 63
6.17 Abbott Laboratories 63
6.17.1 Company Overview 63
6.18 Tyson Bioresearch, Inc. 64
6.18.1 Company Overview 64
6.19 Eumed Biotechnology Co., Ltd. 64
6.19.1 Company Overview 64
6.20 Bioptik Technology, Inc. 64
6.20.1 Company Overview 64
6.21 Bestgen Biotech Corp. 65
6.21.1 Company Overview 65
6.22 Visgeneer, Inc. 65
6.22.1 Company Overview 65
6.23 OK Biotech Co. Ltd. 65
6.23.1 Company Overview 65
6.24 HMD BioMedical Inc. 65
6.24.1 Company Overview 65
6.25 Scienco Technology Corp., Ltd 66
6.25.1 Company Overview 66
6.26 Formosa Biomedical Technology Corp. 66
6.26.1 Company Overview 66
7 Diabetes Care Devices Market Pipeline Products 67
8 Financial Deals Landscape 70
8.1 Acquisition 70
8.1.1 Ypsomed Holding Acquires 10% Equity Stake in BIONIME 70
9 Appendix 71
9.1 Definitions of Markets Covered in the Report 72
9.1.1 Diabetes Care Devices 72
9.2 Research Methodology 74
9.3 Secondary Research 75
9.4 Primary Research 75
9.5 Models 76
9.6 Forecasts 76
9.7 Expert Panels 76
9.8 Currency Conversion 77
9.9 Contact Us 77
9.10 Disclaimer 77
List of Tables
1.1 List of Tables
Table 1: Diabetes Care Devices, Taiwan, Overall Revenue ($m), 2002-2016 11
Table 2: Diabetes Care Devices Market, Taiwan, Category Contribution (%), 2009 13
Table 3: Diabetes Care Devices, Taiwan, Cross-Segment Analysis, 2002-2016 14
Table 4: Diabetes Care Devices, Taiwan, Overall Revenue ($m), Historic, 2002-2009 15
Table 5: Diabetes Care Devices, Taiwan, Overall Revenue ($m), Forecast, 2009-2016 16
Table 6: Diabetes Care Devices, Taiwan, Category Volume (Units), 2002-2016 17
Table 7: Diabetes Care Devices, Taiwan, Category Volume (Units), Historic, 2002-2009 18
Table 8: Diabetes Care Devices, Taiwan, Category Volume (Units), Forecast, 2009-2016 19
Table 9: Diabetes Care Devices, Taiwan, Company Share by Revenue ($m), 2008-2009 21
Table 10: Glucose Monitoring Market, Taiwan, Category Contribution (%), 2009 24
Table 11: Glucose Monitoring, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 25
Table 12: Glucose Monitoring, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 26
Table 13: Blood Glucose Meters, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 27
Table 14: Blood Glucose Meters, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 28
Table 15: Glucose Monitoring, Taiwan, Volume (Units) by Segment, Historic, 2002-2009 29
Table 16: Glucose Monitoring, Taiwan, Volume (Units) by Segment, Forecast, 2009-2016 30
Table 17: Blood Glucose Meters, Taiwan, Volume (Units) by Sub-Segment, Historic, 2002-2009 31
Table 18: Blood Glucose Meters, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2009-2016 32
Table 19: Glucose Monitoring, Taiwan, Average Price ($), Historic, 2002-2009 33
Table 20: Glucose Monitoring, Taiwan, Average Price ($), Forecast, 2009-2016 33
Table 21: Glucose Monitoring, Taiwan, Distribution Share by Revenue ($m), 2008-2009 34
Table 22: Glucose Monitoring, Taiwan, Company Share by Revenue ($m), 2008-2009 36
Table 23: Insulin Delivery Market, Taiwan, Category Contribution (%), 2009 39
Table 24: Insulin Delivery, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 41
Table 25: Insulin Delivery, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 42
Table 26: Insulin Pens, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 43
Table 27: Insulin Pens, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 44
Table 28: Insulin Delivery, Taiwan, Volume (Units) by Segment, Historic, 2002-2009 45
Table 29: Insulin Delivery, Taiwan, Volume (Units) by Segment, Forecast, 2009-2016 46
Table 30: Insulin Pens, Taiwan, Volume (Units) by Sub-Segment, Historic, 2002-2009 47
Table 31: Insulin Pens, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2009-2016 48
Table 32: Insulin Delivery, Taiwan, Average Price ($), Historic, 2002-2009 49
Table 33: Insulin Delivery, Taiwan, Average Price ($), Forecast, 2009-2016 49
Table 34: Insulin Delivery, Taiwan, Distribution Share by Revenue ($m), 2008-2009 50
Table 35: Insulin Delivery, Taiwan, Company Share by Revenue ($m), 2008-2009 52
Table 36: Diabetes Care Devices Pipeline Products 67
Table 37: Ypsomed Holding Acquires 10% Equity Stake In BIONIME 70
Table 38: USD to Local Currency, Taiwan, Average Actual Rate 2002-2009 77
List of Figures
1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation 10
Figure 2: Diabetes Care Devices, Taiwan, Overall Revenue ($m), 2002-2016 11
Figure 3: Diabetes Care Devices Market, Taiwan, Revenue Mix ($m), 2009 12
Figure 4: Diabetes Care Devices Market, Taiwan, Category Contribution (%), 2009 13
Figure 5: Diabetes Care Devices, Taiwan, Cross-Segment Analysis, 2002-2016 14
Figure 6: Diabetes Care Devices, Taiwan, Overall Revenue ($m), Historic, 2002-2009 15
Figure 7: Diabetes Care Devices, Taiwan, Overall Revenue ($m), Forecast, 2009-2016 16
Figure 8: Diabetes Care Devices, Taiwan, Category Volume (Units), 2002-2016 17
Figure 9: Diabetes Care Devices, Taiwan, Category Volume (Units), Historic, 2002-2009 18
Figure 10: Diabetes Care Devices, Taiwan, Category Volume (Units), Forecast, 2009-2016 19
Figure 11: Diabetes Care Devices, Taiwan, Company Share (%), 2009 20
Figure 12: Glucose Monitoring, Market Segmentation 22
Figure 13: Glucose Monitoring Market, Taiwan, Revenue Mix ($m), 2009 23
Figure 14: Glucose Monitoring Market, Taiwan, Category Contribution (%), 2009 24
Figure 15: Glucose Monitoring, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 25
Figure 16: Glucose Monitoring, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 26
Figure 17: Blood Glucose Meters, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 27
Figure 18: Blood Glucose Meters, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 28
Figure 19: Glucose Monitoring, Taiwan, Volume (Units) by Segment, Historic, 2002-2009 29
Figure 20: Glucose Monitoring, Taiwan, Volume (Units) by Segment, Forecast, 2009-2016 30
Figure 21: Blood Glucose Meters, Taiwan, Volume (Units) by Sub-Segment, Historic, 2002-2009 31
Figure 22: Blood Glucose Meters, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2009-2016 32
Figure 23: Glucose Monitoring, Taiwan, Company Share (%), 2009 35
Figure 24: Insulin Delivery, Market Segmentation 37
Figure 25: Insulin Delivery Market, Taiwan, Revenue Mix ($m), 2009 38
Figure 26: Insulin Delivery Market, Taiwan, Category Contribution (%), 2009 39
Figure 27: Insulin Delivery, Taiwan, Revenue ($m) by Segment, Historic, 2002-2009 40
Figure 28: Insulin Delivery, Taiwan, Revenue ($m) by Segment, Forecast, 2009-2016 42
Figure 29: Insulin Pens, Taiwan, Revenue ($m) by Sub-Segment, Historic, 2002-2009 43
Figure 30: Insulin Pens, Taiwan, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 44
Figure 31: Insulin Delivery, Taiwan, Volume (Units) by Segment, Historic, 2002-2009 45
Figure 32: Insulin Delivery, Taiwan, Volume (Units) by Segment, Forecast, 2009-2016 46
Figure 33: Insulin Pens, Taiwan, Volume (Units) by Sub-Segment, Historic, 2002-2009 47
Figure 34: Insulin Pens, Taiwan, Volume (Units) by Sub-Segment, Forecast, 2009-2016 48
Figure 35: Insulin Delivery, Taiwan, Company Share (%), 2009 51
Figure 36: F. Hoffmann-La Roche Ltd, Company Share (%), Taiwan Diabetes Care Devices Market, 2009 53
Figure 37: LifeScan, Inc., Company Share (%), Taiwan Diabetes Care Devices Market, 2009 54
Figure 38: Novo Nordisk A/S, Company Share (%), Taiwan Diabetes Care Devices Market, 2009 55
Figure 39: Bayer HealthCare AG, Company Share (%), Taiwan Diabetes Care Devices Market, 2009 56
Figure 40: Sanofi-Aventis, Company Share (%), Taiwan Diabetes Care Devices Market, 2009 57
Figure 41: ARKRAY, Inc., Company Share (%), Taiwan Diabetes Care Devices Market, 2009 58
Figure 42: GlobalData Methodology 74
About Us
As
Business Overview
ChinaCCM.com is a multinational company headquartered in Hong Kong, with
With more than 19 industry sectors, over 100 vertical and comprehensive channels, ChinaCCM.com can produce the most current and accurate market assessments that will best suit your needs. ChinaCCM.com is home to over 200 senior researchers. Interviews and field research are conducted with local and overseas authorized institutions like
Over the years, we have provided our clients with an unbiased insight on
Products or Services
Market Research
Case Study
Industry Reports
Country Reports
Procurement
Trade Data
Commercial Information Survey
Investment Consultation & Analysis Research
Data & Information Collection Service
Our Advantage
First hand information and efficient service
Wide and well established research network
Understanding product performance and market dynamics
Long term working relationship with government and associations, as well as manufacturers, traders and wholesalers
Contact Information
Andy Cheng
Phone: 86-10-58303339
E-mail: andy@chinaccm.com
Melissa Ma
Price:Negotiable Piece(s)
MOQ:1 Piece(s)
Price:Negotiable Piece(s)
MOQ:1 Piece(s)
Price:Negotiable Piece(s)
MOQ:1 Piece(s)
Price:Negotiable Piece(s)
MOQ:1 Piece(s)
Price:Negotiable Piece(s)
MOQ:1 Piece(s)
Price:Negotiable Piece(s)
MOQ:1 Piece(s)
Price:Negotiable Piece(s)
MOQ:1 Piece(s)
Price:Negotiable Piece(s)
MOQ:1 Piece(s)
Disclaimer: aploo is not responsible for the accuracy, authenticity, or legality of any information posted by suppliers. aploo will not be involved in legal disputes arising from transactions between customers and suppliers. aploo is a platform which connects potential buyers to potential sellers. aploo is not responsible for disagreements and disputes; such disagreements will be negotiated or settled at the expense of the buyer or seller. aploo provides platform service for buyers and sellers instead of self-operated service.
Contact Information: If your legal rights are violated, you are welcomed to send an email to our in-box. For issues arising from infringements, complaints, please contact 1426933299@qq.com.